Targeting angiogenesis in lung cancer

Sameh Daher, Jair Bar*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Angiogenesis inhibition is a promising way to inhibit and eradicate cancer. Many attempts have been made to use this tool for the treatment of lung cancer. Some success has been reported, and antiangiogenic drugs are actively being investigated in combination with other types of anticancer treatments.

Original languageEnglish
Pages (from-to)9-13
Number of pages5
JournalMemo - Magazine of European Medical Oncology
Volume11
Issue number1
DOIs
StatePublished - 1 Mar 2018
Externally publishedYes

Keywords

  • Antiangiogenic drugs
  • Bevacizumab
  • Dual-pathway inhibition

Fingerprint

Dive into the research topics of 'Targeting angiogenesis in lung cancer'. Together they form a unique fingerprint.

Cite this